Global Parenteral Nutrition Market Expected to Reach $11.47 Billion by 2030

Research and Markets, a leading market research firm, has recently released a comprehensive report titled “Parenteral Nutrition Market: Global Industry Analysis, Trends, Market Size, and Forecasts to 2030”. According to the report, the global parenteral nutrition market, valued at USD 6.76 billion in 2022, is projected to reach USD 11.47 billion by 2030, exhibiting a robust CAGR of 5.96% during the forecast period of 2023-2030.

The report offers qualitative and quantitative analysis covering the period from 2021 to 2030, focusing on leading geographies such as North America, Europe, Asia Pacific, and RoW.

Key Market Dynamics

Drivers: The increasing prevalence of chronic diseases, gastrointestinal disorders, and malnutrition serves as a primary driver for the expanding parenteral nutrition market.

Restraints: Limited accessibility and affordability may hinder the widespread adoption of parenteral nutrition.

Opportunities: Advancements in healthcare infrastructure, a growing aging population, and technological innovations in parenteral nutrition present lucrative growth opportunities in the market.

Segmentation Analysis

The global parenteral nutrition market is segmented based on nutrient type, dosage form, end user, patient type, disease type, and distribution channel.

•          Nutrient Type: Carbohydrates, Amino Acids, Lipids, Electrolytes, and Others (Multivitamin Formulations and Trace Elements).

•          Dosage Form: Bags, Vials, Ampules, and Bottles.

•          End User: Clinics, Hospitals, and Others.

•          Patient Type: Pediatrics and Adults.

•          Disease Type: Alzheimer’s, Cancer Care, Diabetes, Chronic Kidney Diseases, and Others.

•          Distribution Channel: Retail Stores, Pharmacies & Drug Stores, Online Channels, and Others.

Company Profiles

The report includes profiles of key players in the parenteral nutrition market, such as B. Braun SE, Fresenius Kabi AG, Allergan/AbbVie, Grifols, S.A., Pfizer Inc., Otsuka Pharmaceutical Factory, Inc., Baxter, Sichuan Kelun Pharmaceutical Co., Ltd., Vifor Pharma Asia Pacific Pte. Ltd., and Aculife. These profiles provide insights into their product portfolios, revenues, SWOT analysis, and latest developments.

What Does This Report Deliver?

•          Comprehensive analysis of the global and regional parenteral nutrition markets.

•          Coverage of all segments in the market, analyzing trends, developments, and forecasting market size up to 2030.

•          In-depth analysis of companies operating in the market, including product portfolios, revenues, SWOT analysis, and recent developments.

•          Growth Matrix analysis guiding market players in investment areas for expansion, consolidation, and diversification.

For more information and to access the full report, visit ResearchAndMarkets.com.

About Research and Markets

Research and Markets is a leading global market research firm providing comprehensive industry reports and consulting services to clients worldwide.

SOURCE: Research and Markets

Related posts:

Global Pneumatic Nebulizers Market to Reach $962.6 Million by 2030 Global Acute Myeloid Leukemia (AML) Therapeutics Market Projected to Reach $1.6 Billion by 2030 Global Injectable Drug Delivery Market Projected to Reach USD 58.90 Billion by 2030 Pediatric Neuroblastoma Treatment Global Market Expected To Reach $2.37 Billion in 2027